TGFB1 and cholangiocarcinoma: The findings of this study suggested that interference of the TGFβ pathway by neutralizing antibodies against TβRII in dendritic cells (DC) caused increased activation of effector T cells and, in turn, enhanced targeting and lysis of co-cultured CCA cells by the immune system [61].